As controls, they used RYR2-isoform ratios from non-failing and DCM heart samples (both negative controls), along with positive controls derived from individuals carrying the proven pathogenic RBM20-p.Pro638Leu variant. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.